Perrigo  president and chief executive Joe Papa. Photograph: Brenda Fitzsimons

In a statement, Perrigo said it had done a deal with Canadian group Transition Therapeutics, the partner in the ELND005 programme(...)

Chief executive Joe Papa said it was an exceptional quarter for Perrigo.  Photograph: Brenda Fitzsimons

Strong growth at its nutritionals and store brand pharmaceutcials divisions drove revenue at Perrigo to record highs in the second quarter of its 2014(...)

Joe Papa: “It has never been my game to be active, outspoken; 
in fact I would say
Perrigo as a company 
that
has made tremendous progress 
as a company
and one of the things we said is to be low profile.” Photograph: Brenda Fitzsimons

The signs on the walls say Elan but Perrigo boss Joe Papa is very much in charge at what was, until recently, Ireland’s largest indigenous drug compan(...)

Perrigo chief executive Joe Papa.

The curtain came down last night on Elan’s existence as an independent company. The acquisition of the business founded in 1969 by Don Panoz to commer(...)

Elan put itself up for sale last month after rejecting three hostile bids from US investment firm Royalty Pharma.

US generic drugmaker Perrigo has agreed to buy fellow drug company Elan for $8.6 billion (€6.48 billion) in a deal that will hand it royalty rights fr(...)